Valerie M. Corrigall
London, ENG SE19AP, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The Biologic IRL201805 Alters Immune Tolerance Leading to Prolonged Pharmacodynamics and Efficacy in Rheumatoid Arthritis Patients.
Journal: International journal of molecular sciences
Published: March 06, 2024
The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases.
Journal: Journal of cellular and molecular medicine
Published: October 24, 2022
Modulation of allergic inflammation in the lung by a peptide derived from Mycobacteria tuberculosis chaperonin 60.1.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: June 12, 2019
Binding Immunoglobulin Protein (BIP) Inhibits TNF-α-Induced Osteoclast Differentiation and Systemic Bone Loss in an Erosive Arthritis Model.
Journal: ACR open rheumatology
Published: February 15, 2019
Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1.
Journal: Clinical and experimental immunology
Published: February 20, 2017
Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: October 19, 2015
Immunoglobulin heavy-chain-binding protein (BiP): a stress protein that has the potential to be a novel therapy for rheumatoid arthritis.
Journal: Biochemical Society transactions
Published: November 18, 2014
Systemic gene transfer of binding immunoglobulin protein (BiP) prevents disease progression in murine collagen-induced arthritis.
Journal: Clinical and experimental immunology
Published: August 26, 2014
Defective CD8+CD28+ regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy.
Journal: Clinical and experimental immunology
Published: June 17, 2013
Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.
Journal: Arthritis and rheumatism
Published: August 01, 2012
Pro-resolution immunological networks: binding immunoglobulin protein and other resolution-associated molecular patterns.
Journal: Rheumatology (Oxford, England)
Published: December 23, 2011
A New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP?
Journal: Frontiers in immunology
Published: December 10, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026